NextGen Healthcare (NXGN) Tops Q2 EPS by 10c, Revenues Beat; Offers FY21 EPS Guidance Above Consensus, FY21 Revenue Mid-Point Outlook Above Consensus

NextGen Healthcare (NASDAQ: NXGN) reported Q2 EPS of $0.30, $0.10 better than the analyst estimate of $0.20. Revenue for the quarter came in at $140 million versus the consensus estimate of $133.04 million.

“We delivered strong Q2 performance across almost every operational metric and showed solid growth in subscription services,” said Rusty Frantz, president and chief executive officer of NextGen Healthcare. “NextGen Healthcare offers a premium client experience in the independent ambulatory market and this differentiator is showing up in our commercial wins both inside and outside the base. We intend to further capitalize on the success of our integrated solution by migrating our client base onto our Spring ‘21 release which leverages our new patient experience platform – opening up additional long-term market opportunities. With better visibility and confidence in the back half of the year, we are resuming annual guidance.”

GUIDANCE:

NextGen Healthcare sees FY2021 EPS of $0.83-$0.93, versus the consensus of $0.79. NextGen Healthcare sees FY2021 revenue of $535-551 million, versus the consensus of $540 million.

For earnings history and earnings-related data on NextGen Healthcare (NXGN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c